VANCOUVER, BC — Nice Genes!, an award winning podcast from Genome British Columbia, is back with a thought-provoking Season 3, exploring the many ways genomics impacts the world. Hosted by Dr. Kaylee… Read More
BOTHELL, Wash. & COPENHAGEN, Denmark–(BUSINESS WIRE)– Seagen Inc. (Nasdaq: SGEN) and Genmab A/S (Nasdaq: GMAB) announced that the Phase 3 innovaTV 301 global trial in recurrent or metastatic cervical cancer… Read More
SOUTH SAN FRANCISCO, CA and VANCOUVER, BC –/CNW/ — ESSA Pharma Inc. (Nasdaq: EPIX) (“ESSA” or the “Company”), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment… Read More
VANCOUVER, BC — Filament Health Corp. (OTCQB:FLHLF) (NEO:FH) (FSE:7QS) (“Filament” or “Filament Health”), a clinical-stage natural psychedelic drug development company, today announced that it has entered into a licensing agreement… Read More
The large-scale facility will support the development and commercialization of the Vertex type 1 diabetes (T1D) cell therapy portfolio At the facility’s groundbreaking event on August 30th, Lonza and Vertex… Read More
